Janus Henderson Group plc 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:56 am Purchase |
2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
5,188,265 12.000% |
1,107,166 (+27.13%) |
Filing |
| 2024-11-14 12:51 pm Sale |
2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
4,081,099 10.500% |
-82,579 (-1.98%) |
Filing |
| 2024-10-03 09:55 am Purchase |
2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
4,163,678 10.100% |
1,639,781 (+64.97%) |
Filing |
| 2024-02-13 5:35 pm Purchase |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
2,523,897 8.300% |
1,064,197 (+72.91%) |
Filing |
| 2023-10-06 11:45 am Purchase |
2023-09-26 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
1,459,700 10.100% |
1,459,700 (New Position) |
Filing |